Vitro Biopharma
Vitro Biopharma, Inc.
Vitro Biopharma, Inc. is a biotechnology company focused on developing innovative cell therapies derived from Wharton's jelly mesenchymal stem cells harvested from umbilical cords. Their research primarily addresses autoimmune diseases and inflammatory disorders, offering potential therapeutic solutions for patients suffering from conditions with limited treatment options.
Products & Team
AlloRx Stem Cell Therapy
A novel cellular therapeutic platform that utilizes culture-expanded mesenchymal stem cells sourced from Wharton's jelly of donated umbilical cords, designed to treat a variety of immune and inflammatory diseases.
AlloRx Stem Cell therapy aims to provide effective treatment options for chronic and debilitating conditions that currently have limited or no effective therapies.
Addressing the lack of effective treatments for chronic autoimmune diseases and providing innovative solutions for rare neurogenetic disorders.